2026, SCIAN|HONSUN has achieved two major international regulatory milestones for its portable concentrator for oxygen. This accomplishment goes beyond a single product breakthrough — it demonstrates our overall competence in respiratory health, validated by the world's most stringent regulatory frameworks.
In June 2026, the portable concentrator for oxygen(models: Ares-6A, Ares-4A) received FDA 510(k) clearance (K252399). Utilizing molecular sieve / pressure swing adsorption (PSA) technology with breath detection, the device delivers pulsed, high-concentration oxygen (90%~96%) for patients requiring supplemental oxygen in home, institutional, and transport settings.
As early as 2025, SCIAN|HONSUN successfully passed TÜV SÜD audits and was granted a Quality Management System Certificate under the EU Medical Device Regulation (EU) 2017/745 (Certificate No. G15 074340 0024 Rev.00). The certification covers comprehensive QMS assessment, including sterilization, metrological traceability, and reusable device management (where applicable), ensuring sustained EU market access.
Portable oxygen concentrators offer greater freedom for oxygen therapy. Unlike traditional oxygen tanks, a home oxygen concentrator provides a continuous oxygen supply at home, while a travel oxygen concentrator is designed for easy portability on the go. To check the portable oxygen concentrator price, you can compare options on portable oxygen concentrator Alibaba; searching portable oxygen concentrator near me can also help you find local suppliers, so you can buy portable oxygen concentrator whenever you need it.
English
